Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07159737Not ApplicableNot Yet Recruiting

Comparison of HYBRID Versus Two-Stent Strategies in Unprotected True Left MAIN Bifurcation

Role: collaborator

NCT07095478Phase 2Not Yet Recruiting

Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer

Role: collaborator

NCT07095309Phase 2Not Yet Recruiting

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

Role: collaborator

All 3 trials loaded